# NILOTINIB D-TARTRATE
> **NDA218922** · New Drug Application · Sponsor: CIPLA · Approved 2025-02-19
## Drug
- **FDA Application Number:** NDA218922
- **Application type:** New Drug Application
- **Brand name:** NILOTINIB D-TARTRATE
- **Generic name:** NILOTINIB
- **Active ingredients:** NILOTINIB D-TARTRATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2025-02-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218922)
---
*AI Analytics · CC0 1.0*